Spark Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Spark Investment Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-17,900	Closed	-$923K	–	726
2018 Q3	$923K	Sell	17,900 -132,700	-88%	-$6.23M	0.05%	395
2018 Q2	$6.28M	Buy	150,600 +108,000	+254%	+$4.79M	0.37%	78
2018 Q1	$1.88M	Buy	+42,600	New	+$2.16M	0.12%	232
2017 Q2	–	Sell	-19,300	Closed	-$775K	–	817
2017 Q1	$775K	Buy	+19,300	New	+$867K	0.05%	458
2016 Q3	–	Sell	-79,400	Closed	-$1.85M	–	853
2016 Q2	$1.85M	Buy	79,400 +12,200	+18%	+$394K	0.17%	194
2016 Q1	$2.72M	Buy	+67,200	New	+$2.73M	0.27%	113

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Spark Investment Management's IONS Position: Q4 2018 in Review

Spark Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2018, closing a stake of 17,900 shares — an estimated $923K sold.

Spark Investment Management first reported a position in IONS in Q1 2016 and held it in 6 quarters. The position peaked at $6.28M in Q2 2018. 329 funds tracked by Wall St. Rank hold IONS as of Q4 2018.

Spark Investment Management reported no remaining Ionis Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Spark Investment Management sold 17,900 Ionis Pharmaceuticals shares in Q4 2018, an estimated $923K.
Spark Investment Management first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 6 quarters.
Spark Investment Management's Ionis Pharmaceuticals position peaked at $6.28M in Q2 2018.
329 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2018.

Based on Spark Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.